Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response

Zunyong Feng,Jing Zhou,Yinhua Liu,Ruixue Xia,Qiang Li,Liang Yan,Qun Chen,Xiaobing Chen,Yuxin Jiang,Gao Chao,Ming Wang,Guoren Zhou,Yijie Zhang,Yongsheng Wang,Hongping Xia
DOI: https://doi.org/10.1038/s41418-021-00750-x
IF: 12.067
2021-03-22
Cell Death and Differentiation
Abstract:Alveolar macrophages (AM) maintain airway immune balance; however, the regulation of heterogeneity of AMs is incompletely understood. We demonstrate that RGS1 coregulates the immunophenotype of AM subpopulations, including pro- and anti-inflammatory, injury- and repair-associated, and pro- and antifibrotic phenotypes, through the PLC-IP3R signal-dependent intracellular Ca<sup>2+</sup> response. Flt3<sup>+</sup> AMs and Tie2<sup>+</sup> AMs had different immune properties, and RGS1 expression in the cells was targeted by exosomes (EXOs) containing miR-223 and miR-27b-3p that were derived from vascular endothelial cells (EnCs) and type II alveolar epithelial cells (EpCs-II), respectively. Imbalance of AMs was correlated with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and pulmonary fibrosis (PF) caused a lack of secretion of CD31<sup>+</sup> and CD74<sup>+</sup> EXOs derived from EnCs and EpCs-II. Timely treatment with EXOs significantly improved endotoxin-induced ALI/ARDS and bleomycin-induced PF in mice. Thus, EnC- and EpC-II-derived EXOs regulate the immune balance of AMs and can be used as potential therapeutic drugs.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?